Skip to main content
SpringerLink
Log in

Minocycline: another second-line option for RA?

  • New Drugs and Therapeutic
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Paulus HE. Minocycline treatment of rheumatoid arthritis. Ann Intern Med 1995 15 Jan; 122(2): 147–8

    PubMed  CAS  Google Scholar 

  2. Kloppenburg M, Breedveld FC, Terwiel JP, et al. Minocycline in active rheumatoid arthritis. A double-blind, placebo-controlled trial. Arthritis Rheum 1994 May; 37(5): 629–36

    CAS  Google Scholar 

  3. Tilley BC, Alarcón GS, Heyse SP, et al. Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. Ann Intern Med 1995 15 Jan; 122(2): 81–9

    CAS  Google Scholar 

  4. Kloppenburg M, Breedveld FC, Dijkmans BAC. Minocycline in rheumatoid arthritis. Rationale and trial results. Clin Immunother 1996 Jan; 5(1): 1–4

    Google Scholar 

  5. Breedveld FC, Dijkmans BAC, Mattie H. Minocycline treatment for rheumatoid arthritis: an open dose finding study. J Rheumatol 1990; 17(1): 43–6

    PubMed  CAS  Google Scholar 

  6. Gough A, Chapman S, Wagstaff K, et al. Minocycline induced autoimmune hepatitis and systemic lupus erythematosus-like syndrome. Br Med J 1996 Jan 20; 312: 169–72

    Article  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Minocycline: another second-line option for RA?. Drugs Ther. Perspect 7, 5–6 (1996). https://doi.org/10.2165/00042310-199607080-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199607080-00002

Search

Navigation